Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Richard Greil et al.|The Lancet Infectious Diseases|2021Cited by 344
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosisMinoru Takaoka, Ziad Mallat, Xiaohui Zhao et al.|Nature|2024Cited by 76
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 PneumoniaVincent Labbé, François Bagate, Damien Contou et al.|JAMA Internal Medicine|2023Cited by 30
Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagyYujiao Zhang, Hafid Ait‐Oufella|Nature Communications|2023Cited by 25
Extracranial anticoagulant related bleedings admitted to intensive care units: a French multicenter retrospective studyThomas Botrel, Hafid Ait‐Oufella, Sibylle Cunat et al.|Critical Care|2023Cited by 4